Longitudinal functional connectivity changes across the clinical spectrum of C9orf72 hexanucleotide repeat expansion carriers
Liwen Zhang, Suvi Häkkinen, Youjin Jung, Maria Luisa Mandelli, Dana Leichter, Chiadi U. Onyike, Julio C. Rojas, Maria Luisa Gorno Tempini, Jennifer S. Yokoyama, Brad F. Boeve, Adam L. Boxer, Leah K. Forsberg, Hilary W. Heuer, Kejal Kantarci, Eliana Marisa Ramos, Howard J. Rosen

TL;DR
This study tracks brain connectivity changes in people with a C9orf72 gene mutation over time, showing that functional networks change even before structural brain changes appear.
Contribution
The study reveals dynamic longitudinal changes in functional connectivity in C9orf72 carriers across clinical stages, independent of gray matter decline.
Findings
Asymptomatic C9orf72 carriers showed baseline hypoconnectivity in key brain networks and longitudinal changes in connectivity.
Symptomatic carriers exhibited baseline hypoconnectivity and longitudinal increases in connectivity in sensorimotor and salience networks.
Higher baseline NfL levels correlated with longitudinal changes in functional connectivity in asymptomatic and symptomatic carriers.
Abstract
A hexanucleotide repeat expansion in C9orf72 is the leading genetic cause of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. There remains a critical need for biomarkers that track disease progression across clinical stages. Cross‐sectionally, intrinsic connectivity networks (ICNs) derived from task‐free fMRI (tf‐fMRI) detects abnormalities in C9orf72 expansion carriers (C9orf72+), even when brain structural differences are subtle (Lee et al., 2017). Few studies have examined longitudinal connectivity changes in C9orf72+, however. We analyzed longitudinal structural and tf‐fMRI data and plasma neurofilament light chain (NfL) concentrations of C9orf72+ recruited from UCSF and the ALLFTD Consortia. Mean time from first to last scan was 2.4±1.3 years. Participants included 36 asymptomatic (aSx‐C9), 17 prodromal (prodromal‐C9), 29 symptomatic (Sx‐C9) carriers, and 107…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAmyotrophic Lateral Sclerosis Research · Genetic Neurodegenerative Diseases · Functional Brain Connectivity Studies
